198 related articles for article (PubMed ID: 4628253)
1. Antitumor effects of interferon.
Gresser I
Adv Cancer Res; 1972; 16():97-140. PubMed ID: 4628253
[No Abstract] [Full Text] [Related]
2. Interferon and cancer: therapeutic prospects.
Gresser I
Rev Eur Etud Clin Biol; 1970 Jan; 15(1):23-7. PubMed ID: 4910000
[No Abstract] [Full Text] [Related]
3. In vivo therapy of oncogenic viruses.
Chirigos MA
Annu Rev Pharmacol; 1969; 9():431-56. PubMed ID: 4307021
[No Abstract] [Full Text] [Related]
4. Interferon inducers: enhancement of viral oncogenesis in mice and rats.
Gazdar AF; Steinberg AD; Spahn GF; Baron S
Proc Soc Exp Biol Med; 1972 Apr; 139(4):1132-7. PubMed ID: 5023305
[No Abstract] [Full Text] [Related]
5. Inhibitory effect of interferon on murine sarcoma and leukaemia virus infection in vitro.
Sarma PS; Shiu G; Baron S; Huebner RJ
Nature; 1969 Aug; 223(5208):845-6. PubMed ID: 4307970
[No Abstract] [Full Text] [Related]
6. The effect of high doses of poly(I).poly(C) induced mouse L cell interferon on Rauscher leukemia virus induced erythroleukemia in BALB/c mice.
Hekman RA; Prins ME; Bosveld IJ; Trapman J
Int J Cancer; 1981; 27(4):493-500. PubMed ID: 6168593
[TBL] [Abstract][Full Text] [Related]
7. Friend virus release and induction of haemoglobin synthesis in erythroleukaemic cells respond differently to interferon.
Swetly P; Ostertag W
Nature; 1974 Oct; 251(5476):642-4. PubMed ID: 4529321
[No Abstract] [Full Text] [Related]
8. [New antigens arising in virus-infected cells].
Kosiakov PN; Charchoglian RA; Posevaia TA; Berdinskikh MS
Vopr Virusol; 1969; 14(5):518-25. PubMed ID: 4334572
[No Abstract] [Full Text] [Related]
9. The interferons and their inducers: molecular and therapeutic considerations. 3.
Grossberg SE
N Engl J Med; 1972 Jul; 287(3):122-8. PubMed ID: 4555741
[No Abstract] [Full Text] [Related]
10. [Oncornaviruses type D and their possible role in neoplastic processes].
Ershov FI; Zhdanov VM
Vopr Onkol; 1977; 23(5):110-9. PubMed ID: 407718
[No Abstract] [Full Text] [Related]
11. Relevance of virus-induced immunodepression to oncogenesis.
Bendinelli M
G Batteriol Virol Immunol; 1974; 67(7-12):173-9. PubMed ID: 4478766
[No Abstract] [Full Text] [Related]
12. Interferon: its inducers and some aspects of host resistance in malignancy.
Merigan TC
Cancer Chemother Rep; 1974; 58(4):571-8. PubMed ID: 4604626
[No Abstract] [Full Text] [Related]
13. Interferons.
Higgins PG
J Clin Pathol; 1984 Feb; 37(2):109-16. PubMed ID: 6198337
[No Abstract] [Full Text] [Related]
14. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors.
Glynn JP; McCoy JL; Fefer A
Cancer Res; 1968 Mar; 28(3):434-9. PubMed ID: 4867923
[No Abstract] [Full Text] [Related]
15. [Interferon--antipode of tumor transforming protein].
Mekler LB
Zh Obshch Biol; 1977; 38(6):863-84. PubMed ID: 341583
[No Abstract] [Full Text] [Related]
16. Antitumor effects of interferons.
Friedman RM
J Exp Pathol; 1987; 3(2):203-27. PubMed ID: 2447252
[No Abstract] [Full Text] [Related]
17. Decrease of sensitivity to interferon in cells infected by murine leukemia-sarcoma viruses.
Périés J; Canivet M; Olivié M; Sallé M; Boiron M
J Natl Cancer Inst; 1973 Aug; 51(2):455-63. PubMed ID: 4797258
[No Abstract] [Full Text] [Related]
18. Interferon induction in cancer: with some observations on the clinical effects of poly 1:C.
Young CW
Med Clin North Am; 1971 May; 55(3):721-8. PubMed ID: 4932880
[No Abstract] [Full Text] [Related]
19. [Interferon - principles and current clinical uses].
Treuner J; Dannecker G
Fortschr Med; 1981 Jun; 99(21):807-13. PubMed ID: 6166525
[No Abstract] [Full Text] [Related]
20. The hormonal concept of interferon. Brief review.
Inglot AD
Arch Virol; 1983; 76(1):1-13. PubMed ID: 6190467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
